Table of Content

1 Anti-Cancer Drug Market Overview
1.1 Anti-Cancer Drug Product Overview
1.2 Anti-Cancer Drug Market Segment by Type
1.2.1 Avastin
1.2.2 Rituxan
1.2.3 Herceptin
1.2.4 Alimta
1.3 Global Anti-Cancer Drug Market Size by Type
1.3.1 Global Anti-Cancer Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Anti-Cancer Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Anti-Cancer Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Cancer Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Anti-Cancer Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Anti-Cancer Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Anti-Cancer Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Anti-Cancer Drug Sales Breakdown by Type (2018-2024)
2 Global Anti-Cancer Drug Market Competition by Company
2.1 Global Top Players by Anti-Cancer Drug Sales (2018-2024)
2.2 Global Top Players by Anti-Cancer Drug Revenue (2018-2024)
2.3 Global Top Players by Anti-Cancer Drug Price (2018-2024)
2.4 Global Top Manufacturers Anti-Cancer Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Cancer Drug Market Competitive Situation and Trends
2.5.1 Anti-Cancer Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Cancer Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Cancer Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-Cancer Drug Market
2.8 Key Manufacturers Anti-Cancer Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Cancer Drug Status and Outlook by Region
3.1 Global Anti-Cancer Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Anti-Cancer Drug Historic Market Size by Region
3.2.1 Global Anti-Cancer Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Anti-Cancer Drug Sales in Value by Region (2018-2024)
3.2.3 Global Anti-Cancer Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Anti-Cancer Drug Forecasted Market Size by Region
3.3.1 Global Anti-Cancer Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Anti-Cancer Drug Sales in Value by Region (2024-2034)
3.3.3 Global Anti-Cancer Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anti-Cancer Drug by Application
4.1 Anti-Cancer Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Home Care
4.2 Global Anti-Cancer Drug Market Size by Application
4.2.1 Global Anti-Cancer Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Anti-Cancer Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Anti-Cancer Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Cancer Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Anti-Cancer Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Anti-Cancer Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Anti-Cancer Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Anti-Cancer Drug Sales Breakdown by Application (2018-2024)
5 North America Anti-Cancer Drug by Country
5.1 North America Anti-Cancer Drug Historic Market Size by Country
5.1.1 North America Anti-Cancer Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Anti-Cancer Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Anti-Cancer Drug Sales in Value by Country (2018-2024)
5.2 North America Anti-Cancer Drug Forecasted Market Size by Country
5.2.1 North America Anti-Cancer Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Anti-Cancer Drug Sales in Value by Country (2024-2034)
6 Europe Anti-Cancer Drug by Country
6.1 Europe Anti-Cancer Drug Historic Market Size by Country
6.1.1 Europe Anti-Cancer Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Anti-Cancer Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Anti-Cancer Drug Sales in Value by Country (2018-2024)
6.2 Europe Anti-Cancer Drug Forecasted Market Size by Country
6.2.1 Europe Anti-Cancer Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Anti-Cancer Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Anti-Cancer Drug by Region
7.1 Asia-Pacific Anti-Cancer Drug Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Cancer Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Anti-Cancer Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Anti-Cancer Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Anti-Cancer Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Cancer Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anti-Cancer Drug Sales in Value by Region (2024-2034)
8 Latin America Anti-Cancer Drug by Country
8.1 Latin America Anti-Cancer Drug Historic Market Size by Country
8.1.1 Latin America Anti-Cancer Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Anti-Cancer Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Anti-Cancer Drug Sales in Value by Country (2018-2024)
8.2 Latin America Anti-Cancer Drug Forecasted Market Size by Country
8.2.1 Latin America Anti-Cancer Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anti-Cancer Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Anti-Cancer Drug by Country
9.1 Middle East and Africa Anti-Cancer Drug Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Cancer Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Anti-Cancer Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Anti-Cancer Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Anti-Cancer Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Cancer Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anti-Cancer Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck Anti-Cancer Drug Products Offered
10.1.5 Merck Recent Development
10.2 Bristol-Myers Squibb
10.2.1 Bristol-Myers Squibb Company Information
10.2.2 Bristol-Myers Squibb Introduction and Business Overview
10.2.3 Bristol-Myers Squibb Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol-Myers Squibb Anti-Cancer Drug Products Offered
10.2.5 Bristol-Myers Squibb Recent Development
10.3 Bayer
10.3.1 Bayer Company Information
10.3.2 Bayer Introduction and Business Overview
10.3.3 Bayer Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bayer Anti-Cancer Drug Products Offered
10.3.5 Bayer Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Information
10.4.2 GlaxoSmithKline Introduction and Business Overview
10.4.3 GlaxoSmithKline Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 GlaxoSmithKline Anti-Cancer Drug Products Offered
10.4.5 GlaxoSmithKline Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Novartis Anti-Cancer Drug Products Offered
10.5.5 Novartis Recent Development
10.6 Sanofi
10.6.1 Sanofi Company Information
10.6.2 Sanofi Introduction and Business Overview
10.6.3 Sanofi Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sanofi Anti-Cancer Drug Products Offered
10.6.5 Sanofi Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Pfizer Anti-Cancer Drug Products Offered
10.7.5 Pfizer Recent Development
10.8 Amgen
10.8.1 Amgen Company Information
10.8.2 Amgen Introduction and Business Overview
10.8.3 Amgen Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Amgen Anti-Cancer Drug Products Offered
10.8.5 Amgen Recent Development
10.9 Celgene Corporation
10.9.1 Celgene Corporation Company Information
10.9.2 Celgene Corporation Introduction and Business Overview
10.9.3 Celgene Corporation Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Celgene Corporation Anti-Cancer Drug Products Offered
10.9.5 Celgene Corporation Recent Development
10.10 Ariad Pharmaceuticals
10.10.1 Ariad Pharmaceuticals Company Information
10.10.2 Ariad Pharmaceuticals Introduction and Business Overview
10.10.3 Ariad Pharmaceuticals Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Ariad Pharmaceuticals Anti-Cancer Drug Products Offered
10.10.5 Ariad Pharmaceuticals Recent Development
10.11 Eli Lilly
10.11.1 Eli Lilly Company Information
10.11.2 Eli Lilly Introduction and Business Overview
10.11.3 Eli Lilly Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Eli Lilly Anti-Cancer Drug Products Offered
10.11.5 Eli Lilly Recent Development
10.12 Hoffmann-La Roche Ltd.
10.12.1 Hoffmann-La Roche Ltd. Company Information
10.12.2 Hoffmann-La Roche Ltd. Introduction and Business Overview
10.12.3 Hoffmann-La Roche Ltd. Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Hoffmann-La Roche Ltd. Anti-Cancer Drug Products Offered
10.12.5 Hoffmann-La Roche Ltd. Recent Development
10.13 AstraZeneca
10.13.1 AstraZeneca Company Information
10.13.2 AstraZeneca Introduction and Business Overview
10.13.3 AstraZeneca Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 AstraZeneca Anti-Cancer Drug Products Offered
10.13.5 AstraZeneca Recent Development
10.14 Boehringer Ingelheim GmbH
10.14.1 Boehringer Ingelheim GmbH Company Information
10.14.2 Boehringer Ingelheim GmbH Introduction and Business Overview
10.14.3 Boehringer Ingelheim GmbH Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Boehringer Ingelheim GmbH Anti-Cancer Drug Products Offered
10.14.5 Boehringer Ingelheim GmbH Recent Development
10.15 Teva Pharmaceuticals
10.15.1 Teva Pharmaceuticals Company Information
10.15.2 Teva Pharmaceuticals Introduction and Business Overview
10.15.3 Teva Pharmaceuticals Anti-Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Teva Pharmaceuticals Anti-Cancer Drug Products Offered
10.15.5 Teva Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Cancer Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Cancer Drug Industrial Chain Analysis
11.4 Anti-Cancer Drug Market Dynamics
11.4.1 Anti-Cancer Drug Industry Trends
11.4.2 Anti-Cancer Drug Market Drivers
11.4.3 Anti-Cancer Drug Market Challenges
11.4.4 Anti-Cancer Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Cancer Drug Distributors
12.3 Anti-Cancer Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Avastin
Table 2. Major Company of Rituxan
Table 3. Major Company of Herceptin
Table 4. Major Company of Alimta
Table 5. Global Anti-Cancer Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Anti-Cancer Drug Sales by Type (2018-2024) & (K Units)
Table 7. Global Anti-Cancer Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Anti-Cancer Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Anti-Cancer Drug Market Share in Value by Type (2018-2024)
Table 10. Global Anti-Cancer Drug Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Anti-Cancer Drug Sales by Type (2024-2034) & (K Units)
Table 12. Global Anti-Cancer Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Anti-Cancer Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Anti-Cancer Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Anti-Cancer Drug Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Anti-Cancer Drug Sales by Type (2018-2024) & (K Units)
Table 17. North America Anti-Cancer Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Anti-Cancer Drug Sales (K Units) by Type (2018-2024)
Table 19. Europe Anti-Cancer Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Anti-Cancer Drug Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Anti-Cancer Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Anti-Cancer Drug Sales (K Units) by Type (2018-2024)
Table 23. Latin America Anti-Cancer Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Anti-Cancer Drug Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Anti-Cancer Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Anti-Cancer Drug Sales by Company (2018-2024) & (K Units)
Table 27. Global Anti-Cancer Drug Sales Share by Company (2018-2024)
Table 28. Global Anti-Cancer Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Anti-Cancer Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Anti-Cancer Drug Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Anti-Cancer Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Anti-Cancer Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Cancer Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Anti-Cancer Drug Market
Table 35. Key Manufacturers Anti-Cancer Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Anti-Cancer Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Anti-Cancer Drug Sales by Region (2018-2024) & (K Units)
Table 39. Global Anti-Cancer Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Anti-Cancer Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Anti-Cancer Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Anti-Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Anti-Cancer Drug Sales by Region (2024-2034) & (K Units)
Table 44. Global Anti-Cancer Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Anti-Cancer Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Anti-Cancer Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Anti-Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Anti-Cancer Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Anti-Cancer Drug Sales by Application (2018-2024) & (K Units)
Table 50. Global Anti-Cancer Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Anti-Cancer Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Anti-Cancer Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Anti-Cancer Drug Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Anti-Cancer Drug Sales by Application (2024-2034) & (K Units)
Table 55. Global Anti-Cancer Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Anti-Cancer Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Anti-Cancer Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Anti-Cancer Drug Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Anti-Cancer Drug Sales by Application (2018-2024) (K Units)
Table 60. North America Anti-Cancer Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Anti-Cancer Drug Sales by Application (2018-2024) (K Units)
Table 62. Europe Anti-Cancer Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Anti-Cancer Drug Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Anti-Cancer Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Anti-Cancer Drug Sales by Application (2018-2024) (K Units)
Table 66. Latin America Anti-Cancer Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Anti-Cancer Drug Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Anti-Cancer Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Anti-Cancer Drug Sales by Country (2018-2024) & (K Units)
Table 70. North America Anti-Cancer Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Anti-Cancer Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Anti-Cancer Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Anti-Cancer Drug Sales by Country (2024-2034) & (K Units)
Table 74. North America Anti-Cancer Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Anti-Cancer Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Anti-Cancer Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Anti-Cancer Drug Sales by Country (2018-2024) & (K Units)
Table 78. Europe Anti-Cancer Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Anti-Cancer Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Anti-Cancer Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Anti-Cancer Drug Sales by Country (2024-2034) & (K Units)
Table 82. Europe Anti-Cancer Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Anti-Cancer Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Anti-Cancer Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Anti-Cancer Drug Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Anti-Cancer Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Anti-Cancer Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Anti-Cancer Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Anti-Cancer Drug Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Anti-Cancer Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Anti-Cancer Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Anti-Cancer Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Anti-Cancer Drug Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Anti-Cancer Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Anti-Cancer Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Anti-Cancer Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Anti-Cancer Drug Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Anti-Cancer Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Anti-Cancer Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Anti-Cancer Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Anti-Cancer Drug Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Anti-Cancer Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Anti-Cancer Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Anti-Cancer Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Anti-Cancer Drug Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Anti-Cancer Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Anti-Cancer Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Anti-Cancer Drug Sales Market Share in Value by Country (2024-2034)
Table 109. Merck Company Information
Table 110. Merck Introduction and Business Overview
Table 111. Merck Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Merck Anti-Cancer Drug Product
Table 113. Merck Recent Development
Table 114. Bristol-Myers Squibb Company Information
Table 115. Bristol-Myers Squibb Introduction and Business Overview
Table 116. Bristol-Myers Squibb Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Bristol-Myers Squibb Anti-Cancer Drug Product
Table 118. Bristol-Myers Squibb Recent Development
Table 119. Bayer Company Information
Table 120. Bayer Introduction and Business Overview
Table 121. Bayer Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Bayer Anti-Cancer Drug Product
Table 123. Bayer Recent Development
Table 124. GlaxoSmithKline Company Information
Table 125. GlaxoSmithKline Introduction and Business Overview
Table 126. GlaxoSmithKline Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. GlaxoSmithKline Anti-Cancer Drug Product
Table 128. GlaxoSmithKline Recent Development
Table 129. Novartis Company Information
Table 130. Novartis Introduction and Business Overview
Table 131. Novartis Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Novartis Anti-Cancer Drug Product
Table 133. Novartis Recent Development
Table 134. Sanofi Company Information
Table 135. Sanofi Introduction and Business Overview
Table 136. Sanofi Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Sanofi Anti-Cancer Drug Product
Table 138. Sanofi Recent Development
Table 139. Pfizer Company Information
Table 140. Pfizer Introduction and Business Overview
Table 141. Pfizer Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Pfizer Anti-Cancer Drug Product
Table 143. Pfizer Recent Development
Table 144. Amgen Company Information
Table 145. Amgen Introduction and Business Overview
Table 146. Amgen Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Amgen Anti-Cancer Drug Product
Table 148. Amgen Recent Development
Table 149. Celgene Corporation Company Information
Table 150. Celgene Corporation Introduction and Business Overview
Table 151. Celgene Corporation Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. Celgene Corporation Anti-Cancer Drug Product
Table 153. Celgene Corporation Recent Development
Table 154. Ariad Pharmaceuticals Company Information
Table 155. Ariad Pharmaceuticals Introduction and Business Overview
Table 156. Ariad Pharmaceuticals Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Ariad Pharmaceuticals Anti-Cancer Drug Product
Table 158. Ariad Pharmaceuticals Recent Development
Table 159. Eli Lilly Company Information
Table 160. Eli Lilly Introduction and Business Overview
Table 161. Eli Lilly Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Eli Lilly Anti-Cancer Drug Product
Table 163. Eli Lilly Recent Development
Table 164. Hoffmann-La Roche Ltd. Company Information
Table 165. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 166. Hoffmann-La Roche Ltd. Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Hoffmann-La Roche Ltd. Anti-Cancer Drug Product
Table 168. Hoffmann-La Roche Ltd. Recent Development
Table 169. AstraZeneca Company Information
Table 170. AstraZeneca Introduction and Business Overview
Table 171. AstraZeneca Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 172. AstraZeneca Anti-Cancer Drug Product
Table 173. AstraZeneca Recent Development
Table 174. Boehringer Ingelheim GmbH Company Information
Table 175. Boehringer Ingelheim GmbH Introduction and Business Overview
Table 176. Boehringer Ingelheim GmbH Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 177. Boehringer Ingelheim GmbH Anti-Cancer Drug Product
Table 178. Boehringer Ingelheim GmbH Recent Development
Table 179. Teva Pharmaceuticals Company Information
Table 180. Teva Pharmaceuticals Introduction and Business Overview
Table 181. Teva Pharmaceuticals Anti-Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 182. Teva Pharmaceuticals Anti-Cancer Drug Product
Table 183. Teva Pharmaceuticals Recent Development
Table 184. Key Raw Materials Lists
Table 185. Raw Materials Key Suppliers Lists
Table 186. Anti-Cancer Drug Market Trends
Table 187. Anti-Cancer Drug Market Drivers
Table 188. Anti-Cancer Drug Market Challenges
Table 189. Anti-Cancer Drug Market Restraints
Table 190. Anti-Cancer Drug Distributors List
Table 191. Anti-Cancer Drug Downstream Customers
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Cancer Drug Product Picture
Figure 2. Global Anti-Cancer Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti-Cancer Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Anti-Cancer Drug Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Avastin
Figure 6. Global Avastin Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Rituxan
Figure 8. Global Rituxan Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Herceptin
Figure 10. Global Herceptin Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Alimta
Figure 12. Global Alimta Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Anti-Cancer Drug Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Anti-Cancer Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Anti-Cancer Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Anti-Cancer Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Anti-Cancer Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Anti-Cancer Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Anti-Cancer Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Anti-Cancer Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Anti-Cancer Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Anti-Cancer Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Anti-Cancer Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Anti-Cancer Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Cancer Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Cancer Drug Revenue in 2022
Figure 27. Anti-Cancer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Home Care
Figure 33. Global Home Care Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Global Anti-Cancer Drug Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Anti-Cancer Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America Anti-Cancer Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Anti-Cancer Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Anti-Cancer Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Anti-Cancer Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Anti-Cancer Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Anti-Cancer Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Anti-Cancer Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Anti-Cancer Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Anti-Cancer Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Anti-Cancer Drug Manufacturing Cost Structure
Figure 47. Anti-Cancer Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed